STAA Staar Surgical Co.
1,406
$46.33
$0.82
(1.80%)
| Watchers | 1,406 |
| 52-Wk Low | $26.66 |
| 52-Wk High | $68.27 |
| Market Cap | $2.24B |
| Volume | 148,751.00 |
| 52-Wk High | $68.27 |
| 52-Wk Low | $26.66 |
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General CounselBusiness Wire • 5 days ago
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer Lenses (EVO ICL) for myopia, astigmatism and presbyopia, today...
Share to Feed
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer Lenses (EVO ICL) for myopia, astigmatism and presbyopia, today...
In recent trading, shares of Staar Surgical Co. (STAA) have crossed above the average analyst 12-month target price of 45.38, changing hands for 45.51/share...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer Lenses (EVO ICL) for myopia, astigmatism and presbyopia, today...
Check out Paul Tudor Jones Stock Picks '
Download GuruFolio Report of Paul Tudor Jones (Updated on 04/03/2024), Check out Jim Simons Stock Picks '
Download GuruFolio Report of Jim Simons (Updated...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer Lenses (EVO ICL) for myopia, astigmatism and presbyopia, comes to the...
Check out Paul Tudor Jones Stock Picks »
Download GuruFolio Report of Paul Tudor Jones (Updated on 03/26/2024), Check out Jim Simons Stock Picks »
Download GuruFolio Report of Jim...
Investors considering a purchase of Staar Surgical Co. (STAA) shares, but cautious about paying the going market price of 38.34/share, might benefit from considering selling puts among the...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer Lenses (EVO ICL) for myopia, astigmatism and presbyopia, today...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer Lenses (ICL) for myopia, astigmatism and presbyopia, today announced...